Episode 945: Dr. Roddy McGee

TL;DR: Rogan hosted his own personal stem-cell doctor for an hour-long infomercial promoting FDA-unapproved amniotic and placental “stem cell” injections — products that independent testing has shown often contain zero living cells and that have caused hospitalizations from bacterial contamination.

Dr. Roddy McGee is a board-certified orthopedic surgeon in Las Vegas — credentialed and operating within his clinical field. But the episode is not a sober discussion of orthopedic surgery. It’s a long-form promotion of commercial amniotic/placental “stem cell” therapies that Rogan himself was a paying customer of, with no disclosure framing and no skeptical counterweight.

The Core Problem: An Infomercial, Not An Interview

Rogan publicly posted photos of himself getting “Applied Biologics FloGraft amniotic fluid therapy” at McGee’s clinic and called it “AMAZING for healing injuries. #science.” (Joe Rogan Facebook post)

He then brought his treating physician onto the show to talk about how great those treatments are, to millions of listeners, without:

Disclosing the financial relationship in any meaningful way
Bringing on a regulatory or evidence-based-medicine counterpoint
Distinguishing between FDA-approved uses and the gray-market injection clinic industry

The Claims Made on Air

Claim: Amniotic/placental “stem cell” injections regenerate damaged joints, tendons, and tissue.
Claim: These products contain live, viable stem cells.
Claim: The treatments are safe and effectively a frontier of medicine being held back by slow regulators.
Claim: The FDA may approve these as “allograft tissue” rather than as drugs, so widespread use is appropriate now.

What the Evidence Actually Says

Interventional Orthopedics Foundation lab testing: Commercial “amniotic stem cell” products tested contained no living cells at all, and did not improve performance of patients’ own stem cells. (Regenexx review of amniotic stem cell testing)
FDA position: Birth-tissue-derived stem cell products marketed for joint or tissue regeneration are unapproved drugs under federal law. The FDA’s enforcement position has been upheld in federal court. (Ropes & Gray Stem Cell Litigation Update, 2024)
Documented patient harm: In 2017–2018, 19 patients were hospitalized with serious infections — including bloodstream infections — after being injected with umbilical-cord-derived “stem cell” products contaminated with bacteria, including E. coli. (Pew Charitable Trusts brief on stem cell harms)
Industry scale: Over 700 clinics in the U.S. were offering unapproved stem cell interventions, primarily using amniotic, placental, or umbilical sources — the exact category McGee’s clinic operates in. (Pew Charitable Trusts)
Peer-reviewed call for regulation: A 2025 PNAS commentary explicitly argues the FDA must regulate these therapies precisely because unproven products are sold direct to patients, often with marketing claims that outrun the data. (PNAS, 2025)

Joe Rogan’s Role

This isn’t a case of Rogan being misled by a guest. He was an active customer and public promoter of the product being discussed.

He invited his own treating physician onto the show.
He had already publicly endorsed the treatment on social media before recording.
He framed unproven therapies as “the next frontier” rather than as an emerging area with serious safety and efficacy concerns.
He did not bring on any skeptical voice, FDA expert, or evidence-based-medicine specialist to contextualize the claims.

The result is functionally an hour-long ad to a young, male, injury-prone audience for a category of treatment that the FDA considers unapproved and that has documented harms.

Why It Matters

JRE’s audience includes a large number of athletes and weekend warriors looking for shortcuts past surgery or rehab. Episodes like this one feed direct-to-consumer demand for the unregulated clinic industry, where products may have no viable cells, may be contaminated, and where patients have been hospitalized and even left blind after injections elsewhere in the same industry category. (FDA must regulate stem cell therapies, PNAS)

A credentialed surgeon promoting his own commercial offering on the largest podcast in the world — with the host as a paying patient — is exactly the dynamic that fuels the gray-market stem cell economy that medical regulators have been trying to rein in for the better part of a decade.